These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 1486988)
41. Site-directed mutagenesis of Clostridium perfringens beta-toxin: expression of wild-type and mutant toxins in Bacillus subtilis. Steinthorsdottir V; Fridriksdottir V; Gunnarsson E; Andrésson OS FEMS Microbiol Lett; 1998 Jan; 158(1):17-23. PubMed ID: 9453152 [TBL] [Abstract][Full Text] [Related]
42. Synergistic and antagonistic hemolytic activities of bacteria of genus Arcanobacterium and CAMP-like hemolysis of Arcanobacterium phocae and Arcanobacterium haemolyticum with Psychrobacter phenylpyruvicus. Ulbegi-Mohyla H; Hassan AA; Kanbar T; Alber J; Lämmler C; Prenger-Berninghoff E; Weiss R; Siebert U; Zschöck M Res Vet Sci; 2009 Oct; 87(2):186-8. PubMed ID: 19249067 [TBL] [Abstract][Full Text] [Related]
43. Bacterial Toxins for Cancer Therapy. Zahaf NI; Schmidt G Toxins (Basel); 2017 Jul; 9(8):. PubMed ID: 28788054 [TBL] [Abstract][Full Text] [Related]
44. In vitro effects of an immunotoxin reactive with a shared B and T cell activation antigen. Harris P; Reed E; Suciu-Foca N Transplant Proc; 1991 Feb; 23(1 Pt 1):309-10. PubMed ID: 1990539 [No Abstract] [Full Text] [Related]
45. Formation of ring-shaped structures on erythrocyte membranes after treatment with botulinolysin, a thiol-activated hemolysin from Clostridium botulinum. Sekiya K; Danbara H; Futaesaku Y; Haque A; Sugimoto N; Matsuda M Infect Immun; 1998 Jun; 66(6):2987-90. PubMed ID: 9596778 [TBL] [Abstract][Full Text] [Related]
46. Two different modes of membrane damaging action by bacterial thiol-activated haemolysins. Möllby R; Thelestam M; Geoffroy C; Alouf JE Toxicon; 1982; 20(1):229-32. PubMed ID: 7080037 [TBL] [Abstract][Full Text] [Related]
47. Interaction of alveolysin A sulfhydryl-activated bacterial cytolytic toxin with thiol group reagents and cholesterol. Geoffroy C; Alouf JE Toxicon; 1982; 20(1):239-41. PubMed ID: 6896246 [No Abstract] [Full Text] [Related]
48. Listeriolysin O as cytotoxic component of an immunotoxin. Bergelt S; Frost S; Lilie H Protein Sci; 2009 Jun; 18(6):1210-20. PubMed ID: 19472336 [TBL] [Abstract][Full Text] [Related]
49. Potential antitumor therapeutic application of Grimontia hollisae thermostable direct hemolysin mutants. Huang SC; Wang YK; Huang WT; Kuo TM; Yip BS; Li TH; Wu TK Cancer Sci; 2015 Apr; 106(4):447-54. PubMed ID: 25640743 [TBL] [Abstract][Full Text] [Related]
50. Isolation of theta-toxin fragments and characterization of its effect on toxin-induced hemolysis. Iwamoto M; Ohno-Iwashita Y Jpn J Med Sci Biol; 1990 Dec; 43(6):270. PubMed ID: 2101156 [No Abstract] [Full Text] [Related]
51. A novel membrane-acting immunotoxin, the immunolysin, with therapeutic potential. Drobniewski FA; Watson GJ; Wawrzynczak EJ; Alouf JE; Thorpe PE Biochem Soc Trans; 1992 Nov; 20(4):318S. PubMed ID: 1486988 [No Abstract] [Full Text] [Related]
52. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology]. Chiron MF Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366 [TBL] [Abstract][Full Text] [Related]